Better2Know Cancer screening

Myeloma (Bone Marrow Cancer) Cancer Screen Nurse Kit

This nurse-visit kit checks blood and urine for six markers linked to myeloma, a type of bone marrow cancer, including a full blood count, protein electrophoresis and Bence-Jones protein. It suits people who want the samples collected at home rather than at a clinic.

  • Subscription available
Sample
Mixed
Collection
Nurse kit: venous draw by a nurse, post to lab; also clinic £395
Results in
5 days
Biomarkers
6
Tests for
  • Bence - Jones Protein
  • Biochemistry Profile
  • Erythrocyte sedimentation rate (ESR)
  • Full blood count (FBC) with a 5-part differential
  • Immunoglobulin test
  • Protein electrophoresis

Test specifications

Provider
Better2Know
Sample type
mixed
Collection method
nurse kit: venous draw by a nurse, post to lab; also clinic £395
Turnaround time
5 days
Biomarkers tested
6
At-home test
No
Doctor reviewed
No
Gender focus
Both

What's tested

6 biomarkers as listed by Better2Know.

  • Bence - Jones Protein
  • Biochemistry Profile
  • Erythrocyte sedimentation rate (ESR)
  • Full blood count (FBC) with a 5-part differential
  • Immunoglobulin test
  • Protein electrophoresis

About this test

Myeloma is a cancer of the bone marrow that can affect the skull, ribs, spine and pelvis. This screen combines six measures from a blood and urine sample: a full blood count with a five-part differential, erythrocyte sedimentation rate, protein electrophoresis, an immunoglobulin test, Bence-Jones protein in urine, and a wider biochemistry profile. Together these are commonly used to flag abnormalities that may need further investigation; the test does not diagnose myeloma or any other condition on its own.

There are no comparable tests listed for this screen yet, so we cannot benchmark its £295 price against a like-for-like peer. A clinic-based version of the same screen is also offered by Better2Know for £395.

The scores show good clinical depth, reflecting the six markers covered, in the 71st percentile of cancer screening tests we track, and a clearly presented listing. It scores lower on results and follow-up, because it is not doctor-reviewed as standard, though the provider says abnormal results should be discussed with a doctor, and it can arrange a private consultation or you can take results to your own GP.

Who is it for?

This suits people who want a broad myeloma-related blood and urine screen without attending a clinic in person, since a nurse visits you to collect the samples. There is not yet a comparable test listed to benchmark this against on price or depth, though Better2Know also offers a clinic-based version of the same six-marker screen for £395 if you would prefer an in-person appointment. If you have symptoms or a family history that concerns you, it is worth discussing with a GP alongside any testing.

How it works

A nurse visits you to take a venous blood sample and collect a urine sample using a kit; you then post these to Better2Know's laboratory. The lab measures a full blood count, ESR, protein electrophoresis, an immunoglobulin test, Bence-Jones protein and a biochemistry profile. Results are typically available within five days of the samples reaching the laboratory, through your secure online patient area. The sheet does not state that results are doctor-reviewed as standard.

Pros & cons

Pros

  • Covers six markers, including protein electrophoresis and Bence-Jones protein, in one screen.
  • Nurse visits you at home, so no clinic appointment is needed.
  • Provider says it can arrange a private doctor consultation for abnormal results.

Cons

  • Not yet enough comparable data to benchmark whether £295 is good value.
  • Results are not doctor-reviewed as standard.
  • Requires both a blood and a urine sample, more involved than a single-sample test.

Our editorial score

Compare Health Test Score Six-marker myeloma screen via nurse home visit kit
Editorial confidence: 9.0/10

This home nurse-visit kit tests blood and urine across six markers associated with myeloma, with results in five days. At £295 there is not yet enough comparable data in our tracking to benchmark its price, and results are not doctor-reviewed as standard, though a clinic-based version of the same screen is also available.

Score breakdown

  • Clarity and documentation 9.0/10

    The listing publishes a detailed description, the full biomarker list, a stated turnaround, clear collection options, the sample type; it does not state what the report looks like.

  • Clinical depth 8.8/10

    6 biomarkers, placing it in the 71st percentile of cancer screening tests we track.

  • Collection convenience 9.0/10

    A blood sample taken at home by a visiting nurse or phlebotomist; with a venous or clinic option as well; a home nurse visit is offered; results in around 5 days, in line with or faster than similar tests.

  • Results and follow-up 3.0/10

    Results are not doctor-reviewed and no consultation is included; the provider does not describe the report format.

  • Trust signals 6.5/10

    Trustpilot 4.2 from 775 reviews; CQC registered; trading 18+ years.

  • Value for money 6.0/10

    £295.00; no comparable tests to benchmark against yet.

Calculated 13 September 2026 from the facts we hold about this test and provider, using our published scoring formula. Scores are not hand-edited.

More in Cancer screening

View all →
Selph

qFIT Bowel Cancer Screening Test

Priced close to the FIT test group median

A stool test using the qFIT method to measure blood in a stool sample, giving a numerical result rather than a simple positive or negative. Suited to adults wanting to check a common early indicator of possible bowel cancer risk.

  • At-home test
8.1 / 10
£59.00
Full review →